IPERBOREAL PHARMA SRL

ACTIVE

VIA L'AQUILA 9, Pescara, Italywww.iperboreal.comPrivateEstablished: 2003-01-01

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2003

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

63.6%

Phase 1

18.2%

Phase 3

18.2%

Trial Status Distribution

Active, not recruiting

18.2%

Completed

27.3%

Recruiting

18.2%

Terminated

9.1%

Withdrawn

27.3%

Clinical Trials

Trials sponsored by this organization (11)

Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.

Phase 3

Recruiting

interventional

Dec 2022170 participants

A Study to Evaluate the EffIcacy and Safety of XyloCore, a low-glucose solution for peritoneal dialysis

Phase 1

Active, not recruiting

interventional

Apr 2022170 participants

A Study to Evaluate the EffIcacy and Safety of XyloCore, a low-glucose solution for peritoneal dialysis

Phase 1

Active, not recruiting

interventional

Mar 2022170 participants

Ultrafiltration Efficacy of a PD Solution Containing Icodextrin-Xylitol-Carnitine

Phase 2

Withdrawn

interventional

Oct 201910 participants

Efficacy and Safety Assessments of a Peritoneal Dialysis Solution Containing Glucose, Xylitol, and L-Carnitine in CAPD

Phase 2

Terminated

interventional

Sep 201911 participants

L-Carnitine as an Osmo-metabolic Agent for Peritoneal Dialysis

Phase 2

Completed

interventional

Jun 20095 participants

Study of Safety and Efficacy on New Peritoneal Dialysis Solutions

Effect of an L-carnitine-containing Peritoneal Dialysis (PD) Solution on Insulin Sensitivity in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD)

Phase 2

Completed

interventional

Jan 200835 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations